Insilico to present its latest research in AI for longevity biotechnology

(InSilico Medicine, Inc.) Alex Zhavoronkov, CEO and founder of Insilico Medicine, will present its latest advances in modern drug development at the Supply Side West Conference in Las Vegas, 8-9 of November. His topic is artificial Intelligence techniques (AI), such as deep learning (DL), reinforcement learning (RL), and generative adversarial networks (GANs), -- generating as much data as possible -- can be used to invent entirely new products.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news